Paratek Pharmaceuticals, Inc. (NASDAQ:PRTK) Posts Basic Consolidated EPS Of $-4.294

0

Paratek Pharmaceuticals, Inc. (NASDAQ:PRTK)managed to report annual basic consolidated EPS of $-4.294, which was for the year ended2015-12-31.The company reported basic consolidated EPS of $-4.294 for the quarter ended 2015-12-31.

EPS from continuing operations

If you look at the performance of the company’s continuing operations, you see that EPS generated from such operations was {EPS_BASIC_CONT_OPER:1541}} for the year ended 2015-12-31. As for the quarter ended 2015-12-31, continuing operations produced EPS of $-1.6923.

EPS contribution from parent

Paratek Pharmaceuticals, Inc. (NASDAQ:PRTK) received of $-4.294 EPS boost from the parent company for the annual period ended

For the year ended 2015-12-31, the parent of Paratek Pharmaceuticals, Inc. (NASDAQ:PRTK) contributed EPS of $-4.294 to the company’s bottom-line. But for the quarter ended 2015-12-31, EPS boost from the parent was cited as $-4.294.

What About Basic net EPS

The basic net EPS that Paratek Pharmaceuticals, Inc. (NASDAQ:PRTK) reported for the year ended 2015-12-31 stood at $-4.29. For the quarter ended 2015-12-31, the company posted basic net EPS of $-4.29.

What About Consolidated Diluted EPS?

Paratek Pharmaceuticals, Inc. (NASDAQ:PRTK)’s consolidated diluted EPS for the year ended 2015-12-31 was reported as $-4.294. For the quarter ended 2015-12-31 the metric was$-4.294.

Basic diluted EPS

The company managed to register diluted EPS from continuing operation of at $-4.294 for the yearended 2015-12-31. But diluted EPS from continuing operations for the quarter ended 2015-12-31 came in at $-4.294.

Net diluted EPS

Net diluted EPS posted by Paratek Pharmaceuticals, Inc. (NASDAQ:PRTK) for the year ended 2015-12-31 was $-4.29. On quarterly basis, net diluted EPS for the quarter ended 2015-12-31 was reported as $-4.29.

What portion of diluted EPS came from parent?

For the annual period ended 2015-12-31, the parent company of Paratek Pharmaceuticals, Inc. (NASDAQ:PRTK) said that it parent company boosted its diluted EPS by$-4.294 in the year ended 2015-12-31. For the quarter ended 2015-12-31, the parent company’s contribution to diluted EPS was $-4.294.

The company reported net basic EPS of $-4.29 for the year ended 2015-12-31 and net basic EPS of $-4.29 for the quarter ended 2015-12-31.

The number of Paratek Pharmaceuticals, Inc. (NASDAQ:PRTK)’s basic shares outstanding at the end of the annual period ended 2015-12-31 was 16.502. That compares with 16.502 basic shares outstanding for the quarter ended 2015-12-31.

Paratek Pharmaceuticals, Inc. (NASDAQ:PRTK) had 16.502 diluted shares outstanding at the end of the annual period ended 2015-12-31. But for the quarter ended 2015-12-31, diluted outstanding shares were 16.502.

1 Chart Pattern Every Investor Should Know

This little-known pattern preceded moves of 578% in ARWR, 562% in LCI, 513% in ICPT, 439% in EGRX, 408% in ADDUS and more...

Click Here to See This Now.

(Visited 10 times, 1 visits today)